Immunome Inc share price logo

Immunome Inc Share Price

NASDAQ: IMNM

Small Cap

$9.20

-0.48

(-4.96%)

as on

Immunome Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $9.22
    $10.27
    downward going graph

    -0.22%

    Downside

    11.63%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.15
    $16.73
    downward going graph

    44.02%

    Downside

    81.85%

    Upside

    downward going graph

Immunome Inc share price movements today

Previous Close
$9.68
Open
$9.63
Volume
1.0M
Day's Low - High
$9.22 - $10.27
52 Week Low - High
$5.15 - $16.73

Immunome Inc Historical Returns

1 Month Return
-2.32 %
3 Month Return
-1.12 %
1 Year Return
-34.19 %
3 Year Return
+ 74.41 %
5 Year Return
0 %

Immunome Inc Stock Fundamentals & Key Indicators

Check Immunome Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$842.6M

EPS (TTM)

-2.0838

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-188.4M

Revenue (TTM)

12.6M

Profit Margin

0.00%

Return On Equity TTM

14915600.00%

Immunome Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunome Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$842.6MNANA0.00%
BUY$61.5B282.7%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.9B54.04%28.2431.86%
BUY$59.2B2.03%14.3331.37%

Stock Returns calculator for Immunome Inc Stock including INR - Dollar returns

The Immunome Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Immunome Inc investment value today

Current value as on today

₹67,658

Returns

₹32,342

(-32.34%)

Returns from Immunome Inc Stock

₹37,458 (-37.46%)

Dollar Returns*

₹5,115 (+5.12%)

Analyst Recommendation on Immunome Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Immunome Inc. Average target price of $23.8

Immunome Inc Share Price Target

Get share price movements and forecasts by analysts on Immunome Inc.

What analysts predicted

61.34%UPSIDE

Target Price

$23.8

Current Price

$9.2

Analyzed by

11 Analysts

Target

$23.80

Immunome Inc target price $23.8, a slight upside of 61.34% compared to current price of $9.2. According to 11 analysts rating.

Immunome Inc Stock's Interest Amongst Investors

Search interest for Immunome Inc Stock has decreased by -68% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-68% versus previous 30 day period

Immunome Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
2
4
3
3
1
2
2
2
2
4
Gross Profit
2
4
3
3
1
2
2
2
2
4
Operating Income
-4
-5
-4
-94
-132
-40
-50
-82
-44
-46
EBITDA
-4
-5
-4
-13
-20
-33
-43
-55
-43
-45
Interest Expense
0
0
-
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-5
-4
-92
-129
-36
-47
-80
-41
-43
Income Tax Expense
0
0
0
0
0
-
-
-
-
-
Net Income
-4
-5
-4
-92
-129
-36
-47
-80
-41
-43
Net Profit Margin
-172.12%
-130.35%
-121.88%
-2421.17%
-12584.26%
-1528.00%
-1618.56%
-2930.93%
-1423.10%
-1080.87%

Immunome Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
6
14
9
Gross Profit
0
0
0
0
0
14
9
Operating Income
-7
-10
-12
-25
-36
-109
-305
EBITDA
-7
-9
-11
-23
-36
-28
-151
Interest Expense
0
0
0
0
0
-
-
Depreciation
0
0
0
0
0
0
2
Income Before Tax
-7
-10
-17
-24
-36
-106
-292
Income Tax Expense
0
0
0
0
0
0
-292
Net Income
-7
-10
-17
-24
-37
-106
-292
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-566.06%
-761.92%
-3240.38%

Immunome Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-5
-4
-92
-129
-36
-47
-80
-41
-43
Operating Cash Flow
-5
-8
-17
-11
-23
-34
-42
-53
-49
Investing Cash Flow
0
0
-30
-37
-81
24
9
5
-64
Financing Cash Flow
-
60
55
219
0
0
20
162
0
Change in Cash
-6
52
8
171
-104
-9
-12
114
-113

Immunome Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-10
-17
-24
-36
-106
-292
Operating Cash Flow
-9
-12
-18
-28
-7
-110
Investing Cash Flow
0
0
0
0
-30
-85
Financing Cash Flow
10
49
27
0
116
240
Change in Cash
0
37
9
-28
78
44

Global Institutional Holdings in Immunome Inc

Funds
Holdings
T. Rowe Price Investment Management,Inc.
8.68%
BlackRock Inc
6.51%
Redmile Group, LLC
6.16%
Enavate Sciences GP, LLC
5.48%
Point72 Asset Management, L.P.
5.01%

Insights on Immunome Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 126.8% return, outperforming this stock by 33.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 76.6% return, outperforming this stock by 116.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, IMNM stock has moved down by -8.0%

About Immunome Inc

immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. this proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. we then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.
OrganisationImmunome Inc
Headquarters18702 North Creek Parkway, Bothell, WA, United States, 98011
IndustryHealth Technology
CEODr. Clay B. Siegall Ph.D.
E-voting on sharesClick here to vote

Key Management of Immunome Inc

Name

Title

Dr. Philip Tsai

Chief Technical Officer

Dr. Jack Higgins Ph.D.

Chief Scientific Officer

Dr. Robert J. Lechleider M.D.

Chief Medical Officer

Mr. Roee Shahar

Executive Vice President of Commercial

Dr. Clay B. Siegall Ph.D.

Chairman, President & CEO

Ms. Sandra G. Stoneman Esq., J.D.

Chief Legal Officer, General Counsel & Corporate Secretary

Mr. Kinney Horn

Chief Business Officer

Mr. Max Rosett

Chief Financial Officer

FAQs

What is Immunome Inc share price today?

Immunome Inc share price today is $9.2 as on at the close of the market. Immunome Inc share today touched a day high of $10.27 and a low of $9.22.

What is the 52 week high and 52 week low for Immunome Inc share?

Immunome Inc share touched a 52 week high of $16.73 on and a 52 week low of $5.15 on . Immunome Inc stock price today i.e. is closed at $9.2,which is 45.01% down from its 52 week high and 78.64% up from its 52 week low.

What is Immunome Inc's market capitalisation today?

Immunome Inc market capitalisation is $0.00T as on .

How to invest in Immunome Inc Stock (IMNM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunome Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunome Inc Shares that will get you 0.1630 shares as per Immunome Inc share price of $9.2 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Immunome Inc Stock (IMNM) from India?

Indian investors can start investing in Immunome Inc (IMNM) shares with as little as ₹88.25 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.50 in Immunome Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunome Inc share’s latest price of $9.2 as on September 13, 2025 at 1:29 am IST, you will get 1.0870 shares of Immunome Inc. Learn more about fractional shares .